The Journal of Digestive Cancer Research(J Dig Cancer Res, JDCR) operates under the guidance of an editorial board, providing expert advice on content, attracting new authors, and encouraging submissions: guidelines for retracting articles; maintenance of the integrity of the academic record; preclusion of business needs from compromising intellectual and ethical standards; publishing corrections, clarifications, retractions, and apologies when needed; and excluding plagiarism and fraudulent data. The editors maintain the following responsibilities: responsibility and authority to reject and accept articles; avoiding any conflict of interest with respect to articles they reject or accept; promoting the publication of corrections or retractions when errors are found; and preservation of the anonymity of reviewers. The editor assumes that all authors listed in a manuscript have agreed with the following policy of JDCR on submission of the manuscript. Except for the negotiated secondary publication, the manuscript submitted to the journal must be previously unpublished and not be under consideration for publication elsewhere. Under any circumstance, the identities of the referees will not be revealed. If a new author should be added or an author should be deleted after the submission, it is the responsibility of the corresponding author to ensure that all of the authors concerned are aware of and agree to the change in authorship. All published manuscripts become the permanent property of the JDCR and must not be published elsewhere without written permission.
It is possible to republish manuscripts if the manuscripts satisfy the conditions for secondary publication of the ICMJE Recommendations (http://www.icmje.org/recommendations/).
Attempting to publish substantially similar work more than once without attribution of the original source(s) is considered a redundant publication. Definition of being substantially similar can be explained as follows: (1) at least one of the authors is common to all reports (it is likely to be plagiarism if there are no common authors); (2) the subject or study populations are same or similar; The methodology is typically identical or nearly so and; (3) the results and interpretation varies little or not at all. For more information, please refer to ICMJE Recommendation (Available at: http://www.icmje.org/recommendations/).
Any requests for such changes in authorship (adding author(s), removing author(s), or re-arranging the order of authors) after the initial manuscript submission and before publication should be explained in writing to the editor in a letter or e-mail from all authors. This letter must be signed by all authors of the paper. A copyright assignment must be completed by every author.
The corresponding author takes primary responsibility for communication with the journal during the manuscript submission, peer review, and publication process. The corresponding author typically ensures that all of the journal’s administrative requirements, such as providing the details of authorship, ethics committee approval, clinical trial registration documentation, and conflict of interest forms and statements, are properly completed, although these duties may be delegated to one or more coauthors. The corresponding author should be available throughout the submission and peer review process to respond to editorial queries in a timely manner, and after publication, should be available to respond to critiques of the work and cooperate with any requests from the journal for data or additional information or questions about the article.
If an article is accepted for publication, the corresponding author will receive the proof and typeset for the publication. Please note that the author is responsible for all statements made in their work, including changes made during the editorial process – authors should check proofs carefully. JDCR recommends authors to keep the corrections to a minimum. Note that proofs should be returned within 48 hours from receipt of the first proof.